UBS lowered the firm’s price target on A2 Milk Company to NZ$7.05 from NZ$7.30 and keeps a Buy rating on the shares. The firm says investors should gain comfort from A2M lifting its FY24 sales growth guidance against the backdrop of a challenging China infant formula market.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>